ICYMI – Q2 2024 – Market Access Society of America Symposium
Facet Attends the Market Access Society of America Symposium [...]
ICYMI – Q2 2024 – FDLI Annual Conference
Facet Attends the Food and Drug Law Institute (FDLI) [...]
ICYMI – Q2 2024 – PET CMC Coalition
Facet Joins PET CMC Coalition In May, Facet joined [...]
Spotlight On Rare Disease Development – Q2 2024 – START Pilot Program Updates
START Pilot Program Updates In our 4Q2023 newsletter, we [...]
Spotlight On Rare Disease Development – Q2 2024 – New RD Hub
New RD Hub On July 17, 2024, the FDA [...]
Industry Focus Q2-2024: Chinese and Indian Biotech Update
Update on Chinese and Indian Biotech In the Spotlight [...]
Industry Focus Q2 2024 – FDA Final Guidance for Lab Developed Tests
Industry Focus: FDA Final Guidance for Laboratory Developed Tests [...]
Industry Focus Q2-2024: Chevron Deference
Supreme Court Overrules Chevron Deference; What Now? June 28, [...]
Facet By The Numbers – Q1 2024
FACET BY THE NUMBERS Total ESG submissions to FDA [...]
FDA Round Up – Q1 2024
FDA ROUNDUP: FDA Urges Sponsors to Conduct Third Party [...]
gET sOCIAL